Table:
begin	end	state
1	11	cytoplasmic
12	29	transmembrane
30	48	non-cytoplasmic
49	69	transmembrane
70	80	cytoplasmic
81	100	transmembrane
101	105	non-cytoplasmic
106	127	transmembrane
128	138	cytoplasmic
139	161	transmembrane
162	172	non-cytoplasmic
173	195	transmembrane
196	240	cytoplasmic
241	262	transmembrane
263	273	non-cytoplasmic
274	294	transmembrane
295	305	cytoplasmic
306	325	transmembrane
326	330	non-cytoplasmic
331	351	transmembrane
352	359	cytoplasmic
360	384	transmembrane
385	397	non-cytoplasmic
398	419	transmembrane
420	440	cytoplasmic

Input:
>Pf1N1B4_4622 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_4622
MSQELRLIRRITLKLIPFLILLYLIAYVDRSAVGFAKLHMGADIGLGDAAYGLGAGLFFI
GYFLLEIPSNLMLDRFGARRWFARIMVTWGAITIGMAFVQGPNSFYVMRFLLGAAEAGFF
PGVLYYITQWFPIRHRGKILGLFILSQPIAMMITGPVSGGLLGMDGIFGLHGWQWLFIVI
GMPAILLTWPVLRYLPDGPQQVKWMDQSEKDWLTGELKKDLEVYGQTRHGNPLHALKDKR
VLLLALFYLPVTLSIYGLGLWLPTLIKQFGGTDLVTGFVSSVPYIFGIIGLLIIPRSSDR
LNDRYGHLAVLYVLGAIGLFLSAWLTVPVLQLAALCLVAFALFSCTAVFWTLPGRFFAGA
SAAAGIALINSVGNLGGYIGPFVIGALKEYTGNLASGLYFLSCVMVFGLVLTGVVYRLLE
RKHVLPADQFAASARGATRT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server